Approval · Notice of Compliance 26664 · 2021
ACH-MYCOPHENOLATE: Notice of Compliance 26664
Issued September 16, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26664
- Date
- September 16, 2021
- Company
- Accord Healthcare IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Labelling Only
- Reason
- Updates to Product Monograph. Updates to Labelling Material
- Canadian reference product
- CELLCEPT
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACH-MYCOPHENOLATE | Not yet assigned | — |
Medicinal ingredients
- MYCOPHENOLATE MOFETIL 250 MG per CAP